Skip to main content
. 2011 Jun 20;2(6):483–489. doi: 10.1111/j.2040-1124.2011.00134.x

Table 2.  Percentages of subjects diagnosed with non‐alcoholic steatohepatitis and scores for steatosis, inflammation, and ballooning, total non‐alcoholic fatty liver disease activity scores and staging of non‐alcoholic steatohepatitis.

NGT IFG DM P‐value
Subjects diagnosed with NASH based on total NAS (%) 21.6 65.2** 41.7 0.0002
Subjects diagnosed with NASH based on the Matteoni classification (%) 40.9 65.2 58.3 0.0503
Steatosis 1.65 ± 0.63 2.00 ± 0.74* 1.83 ± 0.66 0.0493
Inflammation 0.80 ± 0.79 1.17 ± 0.83 0.92 ± 0.73 0.1181
Ballooning 0.84 ± 0.74 1.22 ± 0.60* 1.17 ± 0.81* 0.0226
Total NAS 3.28 ± 1.44 4.39 ± 1.60** 3.92 ± 1.63* 0.0035
Staging of NASH 0.61 ± 0.90 1.09 ± 1.04* 0.97 ± 1.03 0.0419

Values are means ± SD.

*P < 0.05; **P < 0.01 vs normal glucose tolerance.

DM, diabetes; IFG, impaired fasting glucose; NAS, non‐alcoholic fatty liver disease activity scores; NASH, non‐alcoholic steatohepatitis.